1ST Source Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-32,942
| Closed | -$585K | – | 233 |
|
|
2018
Q3 | $585K | Hold |
32,942
| – | – | 0.05% | 146 |
|
|
2018
Q2 | $454K | Hold |
32,942
| – | – | 0.04% | 156 |
|
|
2018
Q1 | $299K | Hold |
32,942
| – | – | 0.02% | 189 |
|
|
2017
Q4 | $141K | Hold |
32,942
| – | – | 0.01% | 233 |
|
|
2017
Q3 | $47K | Hold |
32,942
| – | – | ﹤0.01% | 225 |
|
|
2017
Q2 | $50K | Hold |
32,942
| – | – | ﹤0.01% | 222 |
|
|
2017
Q1 | $84K | Hold |
32,942
| – | – | 0.01% | 228 |
|
|
2016
Q4 | $84K | Hold |
32,942
| – | – | 0.01% | 231 |
|
|
2016
Q3 | $102K | Hold |
32,942
| – | – | 0.01% | 228 |
|
|
2016
Q2 | $106K | Hold |
32,942
| – | – | 0.01% | 225 |
|
|
2016
Q1 | $102K | Hold |
32,942
| – | – | 0.01% | 221 |
|
|
2015
Q4 | $132K | Hold |
32,942
| – | – | 0.02% | 218 |
|
|
2015
Q3 | $151K | Hold |
32,942
| – | – | 0.02% | 244 |
|
|
2015
Q2 | $171K | Hold |
32,942
| – | – | 0.02% | 252 |
|
|
2015
Q1 | $206K | Hold |
32,942
| – | – | 0.02% | 215 |
|
|
2014
Q4 | $207K | Hold |
32,942
| – | – | 0.02% | 214 |
|
|
2014
Q3 | $201K | Hold |
32,942
| – | – | 0.03% | 212 |
|
|
2014
Q2 | $217K | Buy |
+32,942
| New | +$371K | 0.03% | 205 |
|
Other funds holding ECYT
1ST Source Bank's ECYT Position: Q4 2018 in Review
1ST Source Bank sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 32,942 shares — an estimated $585K sold.
1ST Source Bank first reported a position in ECYT in Q2 2014 and held it in 18 quarters. The position peaked at $585K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- 1ST Source Bank reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- 1ST Source Bank sold 32,942 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $585K.
- 1ST Source Bank first reported a position in Endocyte, Inc. Common Stock in Q2 2014 and held it in 18 quarters.
- 1ST Source Bank's Endocyte, Inc. Common Stock position peaked at $585K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on 1ST Source Bank's 13F filing for Q4 2018, filed 11 Feb 2019.